|
SMURF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.88860000047842E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.169000E-04 |
| Normal-vs-Stage2 |
2.683700E-02 |
| Normal-vs-Stage3 |
1.093030E-01 |
| Normal-vs-Stage4 |
2.806000E-01 |
| Stage1-vs-Stage2 |
4.624200E-01 |
| Stage1-vs-Stage3 |
4.756800E-01 |
| Stage1-vs-Stage4 |
6.441800E-01 |
| Stage2-vs-Stage3 |
2.206000E-01 |
| Stage2-vs-Stage4 |
3.766000E-01 |
| Stage3-vs-Stage4 |
9.933600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.57769999997726E-06 |
| Normal-vs-AfricanAmerican |
2.109900E-02 |
| Normal-vs-Asian |
7.435600E-01 |
| Caucasian-vs-AfricanAmerican |
1.840200E-01 |
| Caucasian-vs-Asian |
3.095600E-01 |
| AfricanAmerican-vs-Asian |
4.995600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.56648999999343E-05 |
| Normal-vs-Female |
2.581000E-04 |
| Male-vs-Female |
5.172000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.657700E-02 |
| Normal-vs-Extreme_Weight |
3.476100E-03 |
| Normal-vs-Obese |
9.70649999999518E-05 |
| Normal-vs-Extreme_Obese |
4.705600E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.512400E-01 |
| Normal_Weight-vs-Obese |
3.775000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.253800E-01 |
| Extreme_Weight-vs-Obese |
3.592400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.960600E-01 |
| Obese-vs-Extreme_Obese |
2.813000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.66800000000111E-05 |
| Normal-vs-Age(41-60Yrs) |
1.31690000004792E-06 |
| Normal-vs-Age(61-80Yrs) |
1.243990E-03 |
| Normal-vs-Age(81-100Yrs) |
4.426200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.114600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.236160E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.397200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.686640E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.649400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.532400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.17700000540944E-08 |
| Normal-VS-Type2 PRCC |
2.108800E-01 |
| Normal-VS-KIRP CIMP |
2.853600E-02 |
| Normal-VS-Unclassified PRCC |
3.996900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.802600E-03 |
| Type1 PRCC-VS-KIRP CIMP |
8.197200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.283800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.868420E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.196980E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.781600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.584400E-01 |
| Normal-vs-N1 |
2.234100E-02 |
| Normal-vs-N2 |
1.122560E-01 |
| N0-vs-N1 |
7.762000E-02 |
| N0-vs-N2 |
3.283800E-03 |
| N1-vs-N2 |
1.168440E-01 |
|
|
